The Gaucher disease treatment market is experiencing steady and transformative growth worldwide, driven by increasing awareness of lysosomal storage disorders, enhanced diagnostic capabilities, and advancements in enzyme replacement and substrate reduction therapies. As global healthcare systems prioritize early detection and specialized care for rare diseases, the demand for effective and...